The optimal technological approach to the development of human hybridomas.
Dorfman
N A
NA
D000486:Allergy and Immunology / Q000639:trends; D000912:Antibodies, Neoplasm / Q000276:immunology; D000921:Antibody-Producing Cells / Q000276:immunology; D000951:Antigens, Neoplasm / Q000276:immunology; D001773:Blood Cells / Q000276:immunology; D002459:Cell Fusion; D002472:Cell Transformation, Viral; D002478:Cells, Cultured; D005544:Forecasting; D004854:Herpesvirus 4, Human; D006801:Humans; D006825:Hybridomas / Q000276:immunology*; D007114:Immunization; D007156:Immunologic Memory; D008214:Lymphocytes / Q000276:immunology*; D009369:Neoplasms / Q000276:immunology; D009842:Oligopeptides / Q000138:chemical synthesis / Q000276:immunology; D014066:Palatine Tonsil / Q000166:cytology / Q000276:immunology; D010954:Plasmacytoma / Q000503:physiopathology; D013154:Spleen / Q000276:immunology
D000912:Antibodies, Neoplasm; D000951:Antigens, Neoplasm; D009842:Oligopeptides